Source: https://edoc.mdc-berlin.de/view/divisions/mueller=5Fecrc.html
Timestamp: 2019-04-19 12:42:39+00:00

Document:
Metabolic, mental and immunological effects of normoxic and hypoxic training in multiple sclerosis patients: a pilot study.
Mähler, A. and Balogh, A. and Csizmadia, I. and Klug, L. and Kleinewietfeld, M. and Steiniger, J. and Šušnjar, U. and Müller, D.N. and Boschmann, M. and Paul, F.
Influence of estrogen on individual exercise motivation and bone protection in ovariectomized rats.
Müller, S.T. and Keiler, A.M. and Kräker, K. and Zierau, O. and Bernhardt, R.
Prediction of birth weight small for gestational age with and without preeclampsia by angiogenic markers: an Odense Child Cohort Study.
Bækgaard Thorsen, L.H. and Bjørkholt Andersen, L. and Birukov, A. and Lykkedegn, S. and Dechend, R. and Stener Jørgensen, J. and Thybo Christesen, H.
High-salt diet causes expansion of the lymphatic network and increased lymph flow in skin and muscle of rats.
Karlsen, T.V. and Nikpey, E. and Han, J. and Reikvam, T. and Rakova, N. and Castorena-Gonzalez, J.A. and Davis, M.J. and Titze, J.M. and Tenstad, O. and Wiig, H.
Soluble B7-H4 blood serum levels are elevated in women at high risk for preeclampsia in the first trimester, as well as in patients with confirmed preeclampsia.
Mach, P. and Nolte-Boenigk, L. and Droste, L. and Fox, L. and Frank, M. and Schmidt, B. and Herse, F. and Verlohren, S. and Wicherek, L. and Iannaccone, A. and Birdir, C. and Andrikos, D. and Kimmig, R. and Gellhaus, A. and Köninger, A.
Scientists on the Spot: Salt, the microbiome, and cardiovascular diseases.
Czesnikiewicz-Guzik, M. and Mueller, D.N.
Duration of storage influences the hemoglobin rising effect of red blood cells in patients undergoing major abdominal surgery.
Hunsicker, O. and Hessler, K. and Krannich, A. and Boemke, W. and Braicu, I. and Sehouli, J. and Meyer, O. and Pruß, A. and Spies, C. and Feldheiser, A.
Impacts of microbiome metabolites on immune regulation and autoimmunity.
Haase, S. and Haghikia, A. and Wilck, N. and Müller, D.N. and Linker, R.A.
The role of PAR1 autoantibodies in patients with primary epithelial ovarian cancer.
Kreienbring, K. and Franz, A. and Richter, R. and Dragun, D. and Heidecke, H. and Müller, D. and Mentze, M. and Dechend, R. and Sehouli, J. and Braicu, E.I.
Continuous blood glucose monitoring reveals enormous circadian variations in pregnant diabetic rats.
Golic, M. and Kräker, K. and Fischer, C. and Alenina, N. and Haase, N. and Herse, F. and Schütte, T. and Henrich, W. and Müller, D.N. and Busjahn, A. and Bader, M. and Dechend, R.
Downregulation of p53 drives autophagy during human trophoblast differentiation.
Gauster, M. and Maninger, S. and Siwetz, M. and Deutsch, A. and El-Heliebi, A. and Kolb-Lenz, D. and Hiden, U. and Desoye, G. and Herse, F. and Prokesch, A.
Angiotensin II responsiveness after preeclampsia: translational data from an experimental rat model and early-onset human preeclampsia.
van der Graaf, A.M. and Toering, T.J. and van der Wiel, M.W.K. and Frenay, A.R.S. and Wallukat, G. and Dechend, R. and Navis, G. and Groen, H. and Lely, A.T. and Faas, M.M.
Proliferation of endogenous regulatory T cells improve the pathophysiology associated with placental ischaemia of pregnancy.
Ibrahim, T. and Przybyl, L. and Harmon, A.C. and Amaral, L.M. and Faulkner, J.L. and Cornelius, D. and Cunningham, M.W. and Hünig, T. and Herse, F. and Wallukat, G. and Dechend, R. and LaMarca, B.
Immunoproteasome subunit β5i/LMP7-deficiency in atherosclerosis.
Hewing, B. and Ludwig, A. and Dan, C. and Poetzsch, M. and Hannemann, C. and Petry, A. and Lauer, D. and Görlach, A. and Kaschina, E. and Müller, D.N. and Baumann, G. and Stangl, V. and Stangl, K. and Wilck, N.
Moe, K. and Heidecke, H. and Dechend, R. and Staff, A.C.
Sugulle, M. and Heidecke, H. and Maschke, U. and Herse, F. and Danser, A.H.J. and Mueller, D.N. and Staff, A.C. and Dechend, R.
Placental DAPK1 and autophagy marker LC3B-II are dysregulated by TNF-α in a gestational age-dependent manner.
Prokesch, A. and Blaschitz, A. and Bauer, T. and Moser, G. and Hiden, U. and Zadora, J. and Dechend, R. and Herse, F. and Gauster, M.
High salt intake reprioritizes osmolyte and energy metabolism for body fluid conservation.
Kitada, K. and Daub, S. and Zhang, Y. and Klein, J. D. and Nakano, D. and Pedchenko, T. and Lantier, L. and LaRocque, L.M. and Marton, A. and Neubert, P. and Schröder, A. and Rakova, N. and Jantsch, J. and Dikalova, A.E. and Dikalov, S.I. and Harrison, D.G. and Müller, D.N. and Nishiyama, A. and Rauh, M. and Harris, R. C. and Luft, F.C. and Wassermann, D.H. and Sands, J.M. and Titze, J.
Antikoagulation bei Patienten mit chronischer Niereninsuffizienz: Empfehlungen der Arbeitsgemeinschaft "Herz-Niere" der Deutschen Gesellschaft für Kardiologie - Herz- und Kreislaufforschung und der Deutschen Gesellschaft für Nephrologie [Anticoagulation in patients with chronic kidney disease : Recommendations from the working group "Heart-Kidney" of the German Cardiac Society and the German Society of Nephrology].
Schlieper, G. and Schwenger, V. and Remppis, A. and Keller, T. and Dechend, R. and Massberg, S. and Baldus, S. and Weinreich, T. and Hetzel, G. and Floege, J. and Mahfoud, F. and Fliser, D.
Increased placental sFlt-1 but unchanged PlGF expression in late-onset preeclampsia.
Ehrlich, L. and Hoeller, A. and Golic, M. and Herse, F. and Perschel, F.H. and Henrich, W. and Dechend, R. and Huppertz, B. and Verlohren, S.
Placental expression of sFlt-1 and PlGF in early preeclampsia vs. early IUGR vs. age-matched healthy pregnancies.
Hoeller, A. and Ehrlich, L. and Golic, M. and Herse, F. and Perschel, F.H. and Siwetz, M. and Henrich, W. and Dechend, R. and Huppertz, B. and Verlohren, S.
Protective function of Ahnak1 in vascular healing after wire injury.
Haase, N. and Rüder, C. and Haase, H. and Kamann, S. and Kouno, M. and Morano, I. and Dechend, R. and Zohlnhöfer, D. and Haase, T.
The effect of low-dose proteasome inhibition on pre-existing atherosclerosis in LDL receptor-deficient mice.
Wilck, N. and Fechner, M. and Dan, C. and Stangl, V. and Stangl, K. and Ludwig, A.
Electrocardiographic assessments and cardiac events after fingolimod first dose a comprehensive monitoring study.
Limmroth, V. and Ziemssen, T. and Lang, M. and Richter, S. and Wagner, B. and Haas, J. and Schmidt, S. and Gerbershagen, K. and Lassek, C. and Klotz, L. and Hoffmann, O. and Albert, C. and Schuh, K. and Baier-Ebert, M. and Wendt, G. and Schieb, H. and Hoyer, S. and Dechend, R. and Haverkamp, W.
Vitamin D supplementation reduces some AT1-AA induced downstream targets implicated in preeclampsia including hypertension.
Faulkner, J.L. and Amaral, L.M. and Cornelius, D.C. and Cunningham, M.W. and Ibrahim, T. and Heep, A. and Campbell, N. and Usry, N. and Wallace, K. and Herse, F. and Dechend, R. and LaMarca, B.D.
Role of the receptor Mas in macrophage-mediated inflammation in vivo.
Hammer, A. and Yang, G. and Friedrich, J. and Kovacs, A. and Lee, D.H. and Grave, K. and Jörg, S. and Alenina, N. and Grosch, J. and Winkler, J. and Gold, R. and Bader, M. and Manzel, A. and Rump, L.C. and Müller, D.N. and Linker, R.A. and Stegbauer, J.
Reduced uterine perfusion pressure T-helper 17 cells cause pathophysiology associated with preeclampsia during pregnancy.
Cornelius, D.C. and Amaral, L.M. and Wallace, K. and Campbell, N. and Thomas, A.J. and Scott, J. and Herse, F. and Wallukat, G. and Dechend, R. and LaMarca, B.
Environmental factors in autoimmune diseases and their role in multiple sclerosis.
Jörg, S. and Grohme, D.A. and Erzler, M. and Binsfeld, M. and Haghikia, A. and Müller, D.N. and Linker, R.A. and Kleinewietfeld, M.
Early pregnancy angiogenic markers and spontaneous abortion: an Odense Child Cohort study.
Andersen, L.B. and Dechend, R. and Karumanchi, S.A. and Nielsen, J. and Joergensen, J.S. and Jensen, T.K. and Christesen, H.T.
Medical treatment of stable angina: a tailored therapeutic approach.
Manolis, A.J. and Poulimenos, L.E. and Ambrosio, G. and Kallistratos, M.S. and Lopez-Sendon, J. and Dechend, R. and Mancia, G. and Camm, A.J.
Benefits and risks of aliskiren treatment in patients with type 2 diabetes: analyses of the 3A registry.
Kistner, I. and Zeymer, U. and Dechend, R. and Hagedorn, I. and Riemer, T. and Bramlage, P. and Pittrow, D. and Senges, J. and Schmieder, R.E.
Tubular epithelial NF-κB activity regulates ischemic AKI.
Markó, L. and Vigolo, E. and Hinze, C. and Park, J.K. and Roël, G. and Balogh, A. and Choi, M. and Wübken, A. and Cording, J. and Blasig, I.E. and Luft, F.C. and Scheidereit, C. and Schmidt-Ott, K.M. and Schmidt-Ullrich, R. and Müller, D.N.
Hytönen, J. and Leppänen, O. and Braesen, J.H. and Schunck, W.H. and Mueller, D. and Jung, F. and Mrowietz, C. and Jastroch, M. and von Bergwelt-Baildon, M. and Kappert, K. and Heuser, A. and Drenckhahn, J.D. and Pieske, B. and Thierfelder, L. and Ylä-Herttuala, S. and Blaschke, F.
Angiotensin II type 1 receptor antibodies in childhood kidney transplantation.
Bjerre, A. and Tangeraas, T. and Heidecke, H. and Dragun, D. and Dechend, R. and Staff, A.C.
Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort.
Andersen, L.B. and Dechend, R. and Jørgensen, J.S. and Luef, B.M. and Nielsen, J. and Barington, T. and Christesen, H.T.
The German Hypertension League (Deutsche Hochdruckliga) Quality Seal Protocol for blood pressure-measuring devices: 15-year experience and results from 105 devices for home blood pressure control.
Tholl, U. and Lüders, S. and Bramlage, P. and Dechend, R. and Eckert, S. and Mengden, T. and Nürnberger, J. and Sanner, B. and Anlauf, M.
Hypertensive retinopathy in a transgenic angiotensin-based model.
Reichhart, N. and Haase, N. and Crespo-Garcia, S. and Skosyrski, S. and Herrspiegel, C. and Kociok, N. and Fuchshofer, R. and Dillinger, A. and Poglitsch, M. and Müller, D.N. and Joussen, A.M. and Luft, F.C. and Dechend, R. and Strauß, O.
Two-year outcomes of patients treated with aliskiren under clinical practice conditions: non-interventional prospective study.
Zeymer, U. and Dechend, R. and Riemer, T. and Deeg, E. and Senges, J. and Pittrow, D. and Schmieder, R.
Vitamin D depletion does not affect key aspects of the preeclamptic phenotype in a transgenic rodent model for preeclampsia.
Andersen, L.B. and Golic, M. and Przybyl, L. and Sorensen, G.L. and Jørgensen, J.S. and Fruekilde, P. and von Versen-Höynck, F. and Herse, F. and Højskov, C.S. and Dechend, R. and Christesen, H.T. and Haase, N.
CD74-downregulation of placental macrophage-trophoblastic interactions in preeclampsia.
Przybyl, L. and Haase, N. and Golic, M. and Rugor, J. and Solano, M.E. and Arck, P.C. and Gauster, M. and Huppertz, B. and Emontzpohl, C. and Stoppe, C. and Bernhagen, J. and Leng, L. and Bucala, R. and Schulz, H. and Heuser, A. and Weedon-Fekjær, S. and Johnsen, G.M. and Peetz, D. and Luft, F.C. and Staff, A.C. and Müller, D.N. and Dechend, R. and Herse, F.
Relaxin treatment in an Ang-II-based transgenic reeclamptic-rat model.
Haase, N. and Golic, M. and Herse, F. and Rugor, J. and Linz, D. and Solano, M.E. and Müller, D.N. and Dechend, R.
Vitamin D supplementation improves pathophysiology in a rat model of preeclampsia.
Faulkner, J.L. and Cornelius, D.C. and Amaral, L.M. and Harmon, A.C. and Cunningham, M.W. and Darby, M.M. and Ibrahim, T. and Thomas, D.S. and Herse, F. and Wallukat, G. and Dechend, R. and LaMarca, B.
Convergent evolution within CEA gene families in mammals: hints for species-specific selection pressures.
Kammerer, R. and Herse, F. and Zimmermann, W.
Predictive and prognostic value of sPRR in patients with primary epithelial ovarian cancer.
Kreienbring, K. and Franz, A. and Richter, R. and Dragun, D. and Heidecke, H. and Dechend, R. and Mueller, D.N. and Sehouli, J. and Braicu, E.I.
Blockade of CD40 ligand for intercellular communication reduces hypertension, placental oxidative stress, and AT1-AA in response to adoptive transfer of CD4(+) T lymphocytes from RUPP rats.
Cornelius, D.C. and Castillo, J. and Porter, J. and Amaral, L.M. and Campbell, N. and Paige, A. and Thomas, A.J. and Harmon, A. and Cunningham, M.W. and Wallace, K. and Herse, F. and Wallukat, G. and Dechend, R. and LaMarca, B.D.
High salt reduces the activation of IL-4- and IL-13-stimulated macrophages.
Binger, K.J. and Gebhardt, M. and Heinig, M. and Rintisch, C. and Schroeder, A. and Neuhofer, W. and Hilgers, K. and Manzel, A. and Schwartz, C. and Kleinewietfeld, M. and Voelkl, J. and Schatz, V. and Linker, R.A. and Lang, F. and Voehringer, D. and Wright, M.D. and Hubner, N. and Dechend, R. and Jantsch, J. and Titze, J. and Müller, D.N.
Functional changes in the uterine artery precede the hypertensive phenotype in a transgenic model of hypertensive pregnancy.
Pulgar, V.M. and Yamaleyeva, L.M. and Varagic, J. and McGee, C. and Bader, M. and Dechend, R. and Brosnihan, K.B.
Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine.
Haghikia, A. and Jörg, S. and Duscha, A. and Berg, J. and Manzel, A. and Waschbisch, A. and Hammer, A. and Lee, D.H. and May, C. and Wilck, N. and Balogh, A. and Ostermann, A.I. and Schebb, N.H. and Akkad, D.A. and Grohme, D.A. and Kleinewietfeld, M. and Kempa, S. and Thöne, J. and Demir, S. and Müller, D.N. and Gold, R. and Linker, R.A.
An increased population of regulatory T cells improves the pathophysiology of placental ischemia in a rat model of preeclampsia.
Cornelius, D.C. and Amaral, L.M. and Harmon, A. and Wallace, K. and Thomas, A.J. and Campbell, N. and Scott, J. and Herse, F. and Haase, N. and Moseley, J. and Wallukat, G. and Dechend, R. and LaMarca, B.
Leslie, K. and Whitley, G.S.J. and Herse, F. and Dechend, R. and Ashton, S.V. and Laing, K. and Thilaganathan, B. and Cartwright, J.E.
IL-10 supplementation increases Tregs and decreases hypertension in the RUPP rat model of preeclampsia.
Harmon, A. and Cornelius, D. and Amaral, L. and Paige, A. and Herse, F. and Ibrahim, T. and Wallukat, G. and Faulkner, J. and Moseley, J. and Dechend, R. and LaMarca, B.
New role for the (pro)renin receptor in T cell development.
Geisberger, S. and Maschke, U. and Gebhardt, M. and Kleinewietfeld, M. and Manzel, A. and Linker, R.A. and Chidgey, A. and Dechend, R. and Nguyen, G. and Daumke, O. and Muller, D.N. and Wright, M.D. and Binger, K.J.
Schlembach, D. and Homuth, V. and Dechend, R.
Exacerbation of acute kidney injury by bone marrow stromal cells from rats with persistent renin-angiotensin system activation.
Kankuri, E. and Mervaala, E.E. and Storvik, M. and Ahola, A.M.J. and Levijoki, J. and Müller, D.N. and Finckenberg, P. and Mervaala, E.M.
Placental fractalkine mediates adhesion of THP-1 monocytes to villous trophoblast.
Siwetz, M. and Sundl, M. and Kolb, D. and Hiden, U. and Herse, F. and Huppertz, B. and Gauster, M.
Placental fractalkine is up-regulated in severe early-onset preeclampsia.
Siwetz, M. and Dieber-Rotheneder, M. and Cervar-Zivkovic, M. and Kummer, D. and Kremshofer, J. and Weiss, G. and Herse, F. and Huppertz, B. and Gauster, M.
The impact of age on the benefits and risks of aliskiren treatment: analyses of the 3A registry.
Friedrich, S. and Zeymer, U. and Dechend, R. and Hagedorn, I. and Riemer, T. and Zemmrich, C. and Bramlage, P. and Pittrow, D. and Senges, J. and Schmieder, R.E.
Sodium chloride, SGK1, and Th17 activation.
Binger, K.J. and Linker, R.A. and Muller, D.N. and Kleinewietfeld, M.
Diagnosis of preeclampsia with soluble Fms-like tyrosine kinase 1/placental growth factor ratio: an inter-assay comparison.
Andersen, L.B. and Frederiksen-Møller, B. and Work Havelund, K. and Dechend, R. and Jørgensen, J.S. and Jensen, B.L. and Nielsen, J. and Lykkedegn, S. and Barington, T. and Christesen, H.T.
Dahlmann, A. and Dörfelt, K. and Eicher, F. and Linz, P. and Kopp, C. and Mössinger, I. and Horn, S. and Büschges-Seraphin, B. and Wabel, P. and Hammon, M. and Cavallaro, A. and Eckardt, K.U. and Kotanko, P. and Levin, N.W. and Johannes, B. and Uder, M. and Luft, F.C. and Müller, D.N. and Titze, J.M.
Linz, D. and Hohl, M. and Schuetze, J. and Mahfoud, F. and Speer, T. and Linz, B. and Hübschle, T. and Juretschke, H.P. and Dechend, R. and Geisel, J. and Rütten, H. and Böhm, M.
A potential pathophysiological role for galectins and the renin-angiotensin system in preeclampsia.
Blois, S.M. and Dechend, R. and Barrientos, G. and Staff, A.C.
Preserved functional autonomic phenotype in adult mice overexpressing moderate levels of human alpha-synuclein in oligodendrocytes.
Tank, J. and da Costa-Goncalves, A.C. and Kamer, I. and Qadri, F. and Ubhi, K. and Rockenstein, E. and Diedrich, A. and Masliah, E. and Gross, V. and Jordan, J.
Targeting the ubiquitin-proteasome system in atherosclerosis: status quo, challenges, and perspectives.
Wilck, N. and Ludwig, A.
Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease.
Lee, D.H. and Heidecke, H. and Schröder, A. and Paul, F. and Wachter, R. and Hoffmann, R. and Ellrichmann, G. and Dragun, D. and Waschbisch, A. and Stegbauer, J. and Klotz, P. and Gold, R. and Dechend, R. and Müller, D.N. and Saft, C. and Linker, R.A.
1-Year outcomes of hypertension management in 13,000 outpatients under practice conditions: Prospective 3A registry.
Zeymer, U. and Dechend, R. and Riemer, T. and Kaiser, E. and Senges, J. and Pittrow, D. and Schmieder, R.E.
Besondere Bluthochdruckfälle: Leitlinienempfehlungen der European Society of Cardiology und European Society of Hypertension [Special cases of high blood pressure: Guideline recommendations of the European Society of Cardiology and European Society of Hypertension].
Angiotensin IV is induced in experimental autoimmune encephalomyelitis but fails to influence the disease.
Manzel, A. and Domenig, O. and Ambrosius, B. and Kovacs, A. and Stegbauer, J. and Poglitsch, M. and Mueller, D.N. and Gold, R. and Linker, R.A.
Weedon-Fekjaer, M.S. and Sheng, Y. and Sugulle, M. and Johnsen, G.M. and Herse, F. and Redman, C.W. and Lyle, R. and Dechend, R. and Staff, A.C.
Progesterone supplementation attenuates hypertension and the autoantibody to the angiotensin II type I receptor in response to elevated interleukin-6 during pregnancy.
Amaral, L.M. and Kipprono, L. and Cornelius, D.C. and Shoemaker, C. and Wallace, K. and Moseley, J. and Wallukat, G. and Martin, J.N. and Dechend, R. and Lamarca, B.
Overexpression of CREB protein protects from tunicamycin-induced apoptosis in various rat cell types.
Balogh, A. and Németh, M. and Koloszár, I. and Markó, L. and Przybyl, L. and Jinno, K. and Szigeti, C. and Heffer, M. and Gebhardt, M. and Szeberényi, J. and Müller, D.N. and Sétáló, G. and Pap, M.
Gene expression profiling in PC12 cells infected with an oncolytic Newcastle disease virus strain.
Balogh, A. and Bátor, J. and Markó, L. and Németh, M. and Pap, M. and Sétáló, G. and Müller, D.N. and Csatary, L.K. and Szeberényi, J.
Vitamin D antagonizes negative effects of preeclampsia on fetal endothelial colony forming cell number and function.
von Versen-Höynck, F. and Brodowski, L. and Dechend, R. and Myerski, A.C. and Hubel, C.A.
Macrophages in homeostatic immune function.
Jantsch, J. and Binger, K.J. and Müller, D.N. and Titze, J.
Taking another "look" at sodium.
Titze, J. and Müller, D.N. and Luft, F.C.
Relaxin does not improve angiotensin II-induced target-organ damage.
Haase, N. and Rugor, J. and Przybyl, L. and Qadri, F. and Müller, D.N. and Dechend, R.
Luft, F.C. and Safak, E. and Dechend, R.
Hypertension after preeclampsia and relation to the C1114G polymorphism (rs4606) in RGS2: data from the Norwegian HUNT2 study.
Kvehaugen, A.S. and Melien, Ø. and Holmen, O.L. and Laivuori, H. and Dechend, R. and Staff, A.C.
Behandlung der arteriellen Hypertonie - Aspekte der neuen europäischen Leitlinien [Treatment of arterial hypertension - Issues of the new european guidelines].
Derer, W. and Dechend, R. and Baberg, H.
Role of "western diet" in inflammatory autoimmune diseases.
Manzel, A. and Muller, D.N. and Hafler, D.A. and Erdman, S.E. and Linker, R.A. and Kleinewietfeld, M.
Report on the 5'th scientific meeting of the "Verein zur Foerderung des Wissenschaftlichen Nachwuchses in der Neurologie" (NEUROWIND e.V.) held in Motzen, Germany, Oct. 25th - Oct. 27th, 2013.
Linker, R.A. and Magnus, T. and Korn, T. and Kleinschnitz, C. and Meuth, S.G.
Autophagy and the (pro)renin receptor.
Binger, K.J. and Muller, D.N.
Ambulatory blood pressure monitoring: Is it mandatory for blood pressure control in treated hypertensive patients? Prospective observational study.
Lehmann, M.V. and Zeymer, U. and Dechend, R. and Kaiser, E. and Hagedorn, I. and Deeg, E. and Senges, J. and Schmieder, R.E.
Expression profiling of autophagy associated genes in placentas of preeclampsia.
Goldman-Wohl, D. and Cesla, T. and Smith, Y. and Greenfield, C. and Dechend, R. and Staff, A.C. and Sugulle, M. and Weedon-Fekjær, M.S. and Johnsen, G.M. and Yagel, S. and Haimov-Kochman, R.
Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss.
Giral, M. and Foucher, Y. and Dufay, A. and Van Huyen, J.P.D. and Renaudin, K. and Moreau, A. and Philippe, A. and Hegner, B. and Dechend, R. and Heidecke, H. and Brouard, S. and Cesbron, A. and Castagnet, S. and Devys, A. and Soulillou, J.P. and Dragun, D.
CYP2J2 overexpression protects against arrhythmia susceptibility in cardiac hypertrophy.
Westphal, C. and Spallek, B. and Konkel, A. and Marko, L. and Qadri, F. and Degraff, L.M. and Schubert, C. and Bradbury, J.A. and Regitz-Zagrosek, V. and Falck, J.R. and Zeldin, D.C. and Müller, D.N. and Schunck, W.H. and Fischer, R.
The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human renin and angiotensinogen genes.
Savoia, C. and Arrabito, E. and Parente, R. and Sada, L. and Madaro, L. and Nicoletti, C. and Zezza, L. and Alonzo, A. and Rubattu, S. and Michelini, S. and Muller, D.N. and Volpe, M.
Freitag, N. and Tirado-González, I. and Barrientos, G. and Herse, F. and Thijssen, V.L.J.L. and Weedon-Fekjær, S.M. and Schulz, H. and Wallukat, G. and Klapp, B.F. and Nevers, T. and Sharma, S. and Staff, A.C. and Dechend, R. and Blois, S.M.
Immune cells control skin lymphatic electrolyte homeostasis and blood pressure.
CD4(+) T cells play a critical role in mediating hypertension in response to placental ischemia.
Novotny, S. and Wallace, K. and Herse, F. and Moseley, J. and Darby, M. and Heath, J. and Gill, J. and Wallukat, G. and Martin, J.N. and Dechend, R. and LaMarca, B.
24-h-Langzeitblutdruckmessung (ABDM): Statement der Deutschen Hochdruckliga e. V. DHL (Deutsche Gesellschaft für Hypertonie und Praevention), Sektion Hochdruckdiagnostik [Ambulatory blood pressure monitoring (ABPM): Statement of the German Hypertension League DHL (German Society of Hypertension and Prevention), working group for hypertension diagnostics].
Lüders, S. and Dechend, R. and Eckert, S. and Mengden, T. and Nürnberger, J. and Tholl, U. and Sanner, B.
Seeking the mechanism(s) of action for corticosteroids in HELLP syndrome: SMASH study.
Wallace, K. and Martin, J.N. and Tam, K.T. and Wallukat, G. and Dechend, R. and Lamarca, B. and Owens, M.Y.
Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension.
Herse, F. and Lamarca, B.
Preeclampsia, acute atherosis of the spiral arteries and future cardiovascular disease: Two new hypotheses.
Staff, A.C. and Dechend, R. and Redman, C.W.G.
Long-term follow-up of patients with atherosclerotic renal artery disease.
Safak, E. and Wilke, C. and Derer, W. and Busjahn, A. and Gross, M. and Moeckel, M. and Mueller, D.N. and Luft, F.C. and Dechend, R.
Sugulle, M. and Herse, F. and Seiler, M. and Dechend, R. and Staff, A.C.
IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy.
Dhillion, P. and Wallace, K. and Herse, F. and Scott, J. and Wallukat, G. and Heath, J. and Mosely, J. and Martin, J.N. and Dechend, R. and LaMarca, B.
Guideline adherence in cardiovascular risk assessment and analysis in 15,000 hypertensive German patients in real life: results of the Prospective 3A Registry.
Dechend, R. and Kaiser, E. and Derer, W. and Deeg, E. and Busjahn, A. and Schmieder, R.E. and Zeymer, U.
Activating autoantibodies to the angiotensin receptor are important in mediating hypertension in response to adoptive transfer of RUPP CD4+ T lymphocytes.
Novotny, S.R. and Wallace, K. and Heath, J. and Moseley, J. and Dhillon, P. and Weimer, A. and Wallukat, G. and Herse, F. and Wenzel, K. and Martin, J.N. and Dechend, R. and Lamarca, B.
Inhibition of the renin-angiotensin-aldosterone system: is there room for dual blockade in the cardiorenal continuum?
Volpe, M. and Danser, A.H. and Menard, J. and Waeber, B. and Mueller, D.N. and Maggioni, A.P. and Ruilope, L.M.
Neue Antihypertensiva in Sicht [New antihypertensive drugs].
Derer, W. and Mueller, D.N. and Dechend, R.
Aliskiren for the treatment of essential hypertension under real-life practice conditions: design and baseline data of the prospective 3A registry.
Zeymer, U. and Dechend, R. and Deeg, E. and Kaiser, E. and Senges, J. and Pittrow, D. and Schmieder, R.
IFPA Meeting 2011 workshop report I: Placenta: Predicting future health; roles of lipids in the growth and development of feto-placental unit; placental nutrient sensing; placental research to solve clinical problems - a translational approach.
Acharya, G. and Albrecht, C. and Benton, S.J. and Cotechini, T. and Dechend, R. and Dilworth, M.R. and Duttaroy, A.K. and Grotmol, T. and Heazell, A.E. and Jansson, T. and Johnstone, E.D. and Jones, H.N. and Jones, R.L. and Lager, S. and Laine, K. and Nagirnaja, L. and Nystad, M. and Powell, T. and Redman, C. and Sadovsky, Y. and Sibley, C. and Troisi, R. and Wadsack, C. and Westwood, M. and Lash, G.E.
Verlohren, S. and Stepan, H. and Dechend, R.
Activating autoantibodies against the AT1-receptor in vascular disease.
Dechend, R. and Dragun, D. and Herse, F. and Riemekasten, G. and Schulze-Forster, K. and Mueller, D.N. and Heidecke, H.
Effect of cytochrome P450-dependent epoxyeicosanoids on Ristocetin-induced thrombocyte aggregation.
Jung, F. and Schulz, C. and Blaschke, F. and Muller, D.N. and Mrowietz, C. and Franke, R.P. and Lendlein, A. and Schunck, W.H.
Heparin strongly induces soluble fms-like tyrosine kinase 1 release in vivo and in vitro.
Searle, J. and Mockel, M. and Gwosc, S. and Datwyler, S.A. and Qadri, F. and Albert, G.I. and Holert, F. and Isbruch, A. and Klug, L. and Mueller, D.N. and Dechend, R. and Muller, R. and Vollert, J.O. and Slagman, A. and Mueller, C. and Herse, F.
Prorenin receptor is essential for podocyte autophagy and survival.
Riediger, F. and Quack, I. and Qadri, F. and Hartleben, B. and Park, J.K. and Potthoff, S.A. and Sohn, D. and Sihn, G. and Rousselle, A. and Fokuhl, V. and Maschke, U. and Purfuerst, B. and Schneider, W. and Rump, L.C. and Luft, F.C. and Dechend, R. and Bader, M. and Huber, T.B. and Nguyen, G. and Mueller, D.N.
Peroxisome proliferator-activated receptor-gamma agonists suppress tissue factor overexpression in rat balloon injury model with Paclitaxel infusion.
Park, J.B. and Kim, B.K. and Kwon, Y.W. and Muller, D.N. and Lee, H.C. and Youn, S.W. and Choi, Y.E. and Lee, S.W. and Yang, H.M. and Cho, H.J. and Park, K.W. and Kim, H.S.
Stellenwert der fixen Dreierkombination [The role of triple-drug, fixed-dose combinations for the treatment of hypertension].
Hypertension in response to IL-6 during pregnancy: role of AT1-receptor activation.
Lamarca, B. and Speed, J. and Ray, L.F. and Cockrell, K. and Wallukat, G. and Dechend, R. and Granger, J.
Praxisleitlinien fuer Heimblutdruckmessung [Practice guidelines for home blood pressure measurement].
Mengden, T. and Dechend, R. and Lueders, S. and Eckert, S. and Tholl, U. and Sanner, B.
A simple fluorescent labeling technique to study virus adsorption in Newcastle disease virus infected cells.
Balogh, A. and Pap, M. and Marko, L. and Koloszar, I. and Csatary, L.K. and Szeberenyi, J.
Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension.
Parrish, M.R. and Wallace, K. and Tam Tam, K.B. and Herse, F. and Weimer, A. and Wenzel, K. and Wallukat, G. and Ray, L.F. and Arany, M. and Cockrell, K. and Martin, J.N. and Dechend, R. and Lamarca, B.
17(R),18(S)-epoxyeicosatetraenoic acid, a potent eicosapentaenoic acid (EPA) derived regulator of cardiomyocyte contraction: structure-activity relationships and stable analogues.
Falck, J.R. and Wallukat, G. and Puli, N. and Goli, M. and Arnold, C. and Konkel, A. and Rothe, M. and Fischer, R. and Mueller, D.N. and Schunck, W.H.
Angiotensin II type 1 autoantibody induced hypertension during pregnancy is associated with renal endothelial dysfunction.
Parrish, M.R. and Ryan, M.J. and Glover, P. and Brewer, J. and Ray, L. and Dechend, R. and Martin, J.N. and Lamarca, B.B.
Mueller, D.N. and Kleinewietfeld, M. and Kvakan, H.
Involvement of functional autoantibodies against vascular receptors in systemic sclerosis.
Riemekasten, G. and Philippe, A. and Naether, M. and Slowinski, T. and Mueller, D.N. and Heidecke, H. and Matucci-Cerinic, M. and Czirjak, L. and Lukitsch, I. and Becker, M. and Kill, A. and van Laar, J.M. and Catar, R. and Luft, F.C. and Burmester, G.R. and Hegner, B. and Dragun, D.
Effects of aliskiren on stroke in rats expressing human renin and angiotensinogen genes.
Schmerbach, K. and Pfab, T. and Zhao, Y. and Culman, J. and Mueller, S. and Villringer, A. and Mueller, D.N. and Hocher, B. and Unger, T. and Thoene-Reineke, C.
Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of omega-3 fatty acids.
Arnold, C. and Markovic, M. and Blossey, K. and Wallukat, G. and Fischer, R. and Dechend, R. and Konkel, A. and von Schacky, C. and Luft, F.C. and Mueller, D.N. and Rothe, M. and Schunck, W.H.
Levosimendan improves cardiac function and survival in rats with angiotensin II-induced hypertensive heart failure.
Biala, A. and Martonen, E. and Kaheinen, P. and Levijoki, J. and Finckenberg, P. and Merasto, S. and Louhelainen, M. and Mueller, D.N. and Luft, F.C. and Mervaala, E.
The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy.
Parrish, M.R. and Murphy, S.R. and Rutland, S. and Wallace, K. and Wenzel, K. and Wallukat, G. and Keiser, S. and Ray, L.F. and Dechend, R. and Martin, J.N. and Granger, J.P. and Lamarca, B.
The (pro)renin receptor and the mystic HRP -Is there a role in cardiovascular disease?
Maschke, U. and Mueller, D.N.
Biala, A. and Tauriainen, E. and Siltanen, A. and Shi, J. and Merasto, S. and Louhelainen, M. and Martonen, E. and Finckenberg, P. and Mueller, D.N. and Mervaala, E.
Changes in endovascular trophoblast invasion and spiral artery remodelling at term in a transgenic preeclamptic rat model.
Geusens, N. and Hering, L. and Verlohren, S. and Luyten, C. and Drijkoningen, K. and Taube, M. and Vercruysse, L. and Hanssens, M. and Dechend, R. and Pijnenborg, R.
alpha(1A)-adrenergic receptor-directed autoimmunity induces left ventricular damage and diastolic dysfunction in rats.
Wenzel, K. and Wallukat, G. and Qadri, F. and Huebner, N. and Schulz, H. and Hummel, O. and Herse, F. and Heuser, A. and Fischer, R. and Heidecke, H. and Luft, F.C. and Mueller, D.N. and Dietz, R. and Dechend, R.
Aldosteronantagonisten: Welchen Stellenwert haben sie in der antihypertensien Therapie? [Mineralocorticoid receptor antagonists: inhibition of the renin angiotensin system].
Derer, W. and Dechend, R. and Mueller, D.N.
The biology of the (pro)renin receptor.
Nguyen, G. and Mueller, D.N.
Milk products containing bioactive tripeptides have an antihypertensive effect in double transgenic rats (dTGR) harbouring human renin and human angiotensinogen genes.
Jauhiainen, T. and Pilvi, T. and Cheng, Z.J. and Kautiainen, H. and Mueller, D.N. and Vapaatalo, H. and Korpela, R. and Mervaala, E.
New approaches to pathogenesis and management of hypertension.
Ritz, E. and Krum, H. and Schlaich, M. and Whitbourn, R. and Sobotka, P.A. and Sadowski, J. and Bartus, K. and Kapelak, B. and Walton, A. and Sievert, H. and Thambar, S. and Abraham, W.T. and Esler, M. and Wang, Y. and Tsun, Z. and Machnik, A. and Neuhofer, W. and Jantsch, J. and Dahlmann, A. and Tammela, T. and Machura, K. and Park, J.K. and Beck, F.X. and Mueller, D.N. and Derer, W. and Goss, J. and Ziomber, A. and Dietsch, P. and Wagner, H. and van Rooijen, N. and Kurtz, A. and Hilgers, K.F. and Alitalo, K. and Eckardt, K.U. and Luft, F.C. and Kerjaschki, D. and Titze, J.
Antihypertensive Behandlung. Bei Risikopatienten von Anfang an fix kombinieren [Fixed-dose combinations in antihypertensive treatment: is it necessary to examine the effectiveness of each component?].
Dechend, R. and Derer, W. and Mueller, D.N.
Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system.
Stegbauer, J. and Lee, D.H. and Seubert, S. and Ellrichmann, G. and Manzel, A. and Kvakan, H. and Mueller, D.N. and Gaupp, S. and Rump, L.C. and Gold, R. and Linker, R.A.
Thomas, C.P. and Andrews, J.I. and Raikwar, N.S. and Kelley, E.A. and Herse, F. and Dechend, R. and Golos, T.G. and Liu, K.Z.
Herse, F. and Bai, Y. and Staff, A.C. and Jiang, Y.M. and Dechend, R. and Zhou, R.
Endogenous angiotensinergic system in neurons of rat and human trigeminal ganglia.
Imboden, H. and Patil, J. and Nussberger, J. and Nicoud, F. and Hess, B. and Ahmed, N. and Schaffner, T. and Wellner, M. and Mueller, D. and Inagami, T. and Senbonmatsu, T. and Pavel, J. and Saavedra, J.M.
Battle against the renin-angiotensin system: help from an unexpected party.
Mueller, D. and Mueller, D.N.
Long-term clopidogrel administration following severe coronary injury reduces proliferation and inflammation via inhibition of nuclear factor-κB and activator protein 1 activation in pigs.
Pels, K. and Schwimmbeck, P.L. and Rosenthal, P. and Loddenkemper, C. and Dang-Heine, C. and Rauch, U. and Martens, H. and Schultheiss, H.P. and Dechend, R. and Deiner, C.
Rosuvastatin protects against angiotensin II-induced renal injury in a dose-dependent fashion.
Park, J.K. and Mervaala, E.M. and Mueller, D.N. and Menne, J. and Fiebeler, A. and Luft, F.C. and Haller, H.
Hypertonie und Schwangerschaft [Hypertension and pregnancy].
Homuth, V. and Derer, W. and Dechend, R.
Dechend, R. and Luft, F.C and Lindheimer, M.D.
Cellular and molecular mechanisms of tissue protection by lipophilic calcium channel blockers.
Menne, J. and Park, J.K. and Agrawal, R. and Lindschau, C. and Kielstein, J.T. and Kirsch, T. and Marx, A. and Muller, D. and Bahlmann, F.H. and Meier, M. and Bode-Böger, S.M. and Haller, H. and Fliser, D.
Direct renin inhibition with aliskiren in hypertension and target organ damage.
Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia.
Dechend, R. and Homuth, V. and Wallukat, G. and Mueller, D.N. and Krause, M. and Dudenhausen, J. and Haller, H. and Luft, F.C.
Complement activation in angiotensin II-induced organ damage.
Shagdarsuren, E. and Wellner, M. and Braesen, J.H. and Park, J.K. and Fiebeler, A. and Henke, N. and Dechend, R. and Gratze, P. and Luft, F.C. and Mueller, D.N.
Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily.
Barbosa-Sicard, E. and Markovic, M. and Honeck, H. and Christ, B. and Muller, D.N. and Schunck, W.H.
Activating auto-antibodies against the AT1 receptor in preeclampsia.
Dechend, R. and Mueller, D.N. and Wallukat, G. and Homuth, V. and Krause, M. and Dudenhausen, J. and Luft, F.C.
Cardiac gene expression profile in rats with terminal heart failure and cachexia.
Wellner, M. and Dechend, R. and Park, J.K. and Shagdasuren, E. and Al-Saadi, N. and Kirsch, T. and Gratze, P. and Schneider, W. and Meiners, S. and Fiebeler, A. and Haller, H. and Luft, F.C. and Mueller, D.N.
Inducible NOS inhibition, eicosapentaenoic acid supplementation, and angiotensin II-induced renal damage.
Theuer, J. and Shagdarsuren, E. and Muller, D.N. and Kaergel, E. and Honeck, H. and Park, J.K. and Fiebeler, A. and Dechend, R. and Haller, H. and Luft, F.C. and Schunck, W.H.
Magnesium supplementation prevents angiotensin II-induced myocardial damage and CTGF overexpression.
Finckenberg, P. and Merasto, S. and Louhelainen, M. and Lindgren, L. and Vapaatalo, H. and Mueller, D.N. and Luft, F.C. and Mervaala, E.M.
AT1 receptor agonistic antibodies, hypertension, and preeclampsia.
Nitric oxide synthase expression in AT receptor-deficient mice after DOCA-salt.
Obst, M. and Gross, V. and Bonartsev, A. and Janke, J. and Mueller, D.N. and Park, J.K. and Kaergel, E. and Luft, F.C.
Cardiac hypertrophy and fibrosis in chronic L-NAME-treated AT2 receptor-deficient mice.
Gross, V. and Obst, M. and Kiss, E. and Janke, J. and Mazak, I. and Shagdarsuren, E. and Mueller, D.N. and Langenickel, T.H. and Groene, H.J. and Luft, F.C.
A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury.
Muller, D.N. and Theuer, J. and Shagdarsuren, E. and Kaergel, E. and Honeck, H. and Park, J.K. and Markovic, M. and Barbosa-Sicard, E. and Dechend, R. and Wellner, M. and Kirsch, T. and Fiebeler, A. and Rothe, M. and Haller, H. and Luft, F.C. and Schunck, W.H.
Growth arrest specific protein 6/Axl signaling in human inflammatory renal diseases.
Fiebeler, A. and Park, J.K. and Muller, D.N. and Lindschau, C. and Mengel, M. and Merkel, S. and Banas, B. and Luft, F.C. and Haller, H.
Lipoic acid supplementation prevents angiotensin II-induced renal injury.
Mervaala, E. and Finckenberg, P. and Lapatto, R. and Mueller, D.N. and Park, J.K. and Dechend, R. and Ganten, D. and Vapaatalo, H. and Luft, F.C.
Angiotensin II and endothelin induce inflammation and thereby promote hypertension-induced end-organ damage.
Mueller, D.N. and Fiebeler, A. and Park, J.K. and Dechend, R. and Luft, F.C.
Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways.
Finckenberg, P. and Inkinen, K. and Ahonen, J. and Merasto, S. and Louhelainen, M. and Vapaatalo, H. and Mueller, D. and Ganten, D. and Luft, F.C. and Mervaala, E.
Entacapone protects from angiotensin II-induced inflammation and renal injury.
Helkamaa, T. and Finckenberg, P. and Louhelainen, M. and Merasto, S. and Rauhala, P. and Lapatto, R. and Cheng, Z.J. and Reenilae, I. and Maennistoe, P. and Mueller, D.N. and Luft, F.C. and Mervaala, E.M.
Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects.
Park, J.K. and Mueller, D.N. and Mervaala, E.M.A. and Dechend, R. and Fiebeler, A. and Schmidt, F. and Bieringer, M. and Schaefer, O. and Lindschau, C. and Schneider, W. and Ganten, D. and Luft, F.C. and Haller, H.
Angiotensin II (AT1) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.
Mueller, D.N. and Mervaala, E.M.A. and Dechend, R. and Fiebeler, A. and Park, J.K. and Schmidt, F. and Theuer, J. and Breu, V. and Mackman, N. and Luther, T. and Schneider, W. and Gulba, D. and Ganten, D. and Haller, H. and Luft, F.C.
This list was generated on Fri Apr 19 02:25:48 2019 CEST.

References: V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V.